|
TBK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.411700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.381400E-04 |
| Normal-vs-Stage2 |
4.511700E-02 |
| Normal-vs-Stage3 |
1.027510E-02 |
| Normal-vs-Stage4 |
5.324500E-03 |
| Stage1-vs-Stage2 |
6.132600E-01 |
| Stage1-vs-Stage3 |
9.440400E-01 |
| Stage1-vs-Stage4 |
7.514800E-01 |
| Stage2-vs-Stage3 |
6.682200E-01 |
| Stage2-vs-Stage4 |
7.570600E-01 |
| Stage3-vs-Stage4 |
8.521600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.552520E-04 |
| Normal-vs-AfricanAmerican |
2.565200E-01 |
| Normal-vs-Asian |
8.863700E-02 |
| Caucasian-vs-AfricanAmerican |
5.045800E-02 |
| Caucasian-vs-Asian |
8.523600E-01 |
| AfricanAmerican-vs-Asian |
3.063800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.398500E-03 |
| Normal-vs-Female |
7.87700000000058E-05 |
| Male-vs-Female |
1.720180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.466200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.249500E-04 |
| Normal-vs-Age(61-80Yrs) |
9.570500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.880800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.387550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.879990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.677000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.647000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.747600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.597000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.277300E-03 |
| Normal-vs-Grade 2 |
1.441640E-04 |
| Normal-vs-Grade 3 |
1.472500E-02 |
| Normal-vs-Grade 4 |
2.387600E-02 |
| Grade 1-vs-Grade 2 |
6.193600E-01 |
| Grade 1-vs-Grade 3 |
1.300000E-01 |
| Grade 1-vs-Grade 4 |
3.791200E-01 |
| Grade 2-vs-Grade 3 |
3.603900E-02 |
| Grade 2-vs-Grade 4 |
3.241600E-01 |
| Grade 3-vs-Grade 4 |
5.707400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.92672999999033E-05 |
| Normal-vs-ccB subtype |
6.384100E-03 |
| ccA subtype-vs-ccB subtype |
1.234430E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.363500E-04 |
| Normal-vs-N1 |
8.729700E-02 |
| N0-vs-N1 |
5.402800E-01 |
|
|
